Desoximetasone (Page 2 of 2)

ADVERSE REACTIONS

The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence:

Burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, and miliaria.

In controlled clinical studies the incidence of adverse reactions was low (0.3%) for desoximetasone ointment USP, 0.25% and included mild burning sensation at the site of application.

OVERDOSAGE

Topically applied corticosteroids can be absorbed in sufficient amounts to produce systemic effects (see PRECAUTIONS).

DOSAGE AND ADMINISTRATION

Apply a thin film of desoximetasone ointment USP, 0.25% to the affected skin areas twice daily. Rub in gently.

HOW SUPPLIED

Desoximetasone Ointment USP, 0.25% is supplied in 15 gram (NDC 40032-024-61) and 60 gram (NDC 40032-024-60) tubes.

Store at controlled room temperature between 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F). [See USP Controlled Room Temperature]

Manufactured by:

Novel Laboratories, Inc

Somerset, NJ 08873

PI0240000101

Iss. 10/2015

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

15 g Tube carton

NDC 40032-024-61

C:\Users\kvyas\Desktop\Desoximetasone\15 g carton.jpg
(click image for full-size original)
DESOXIMETASONE
desoximetasone ointment
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:40032-024
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DESOXIMETASONE (DESOXIMETASONE) DESOXIMETASONE 2.5 mg in 1 g
Inactive Ingredients
Ingredient Name Strength
COCONUT OIL
PETROLATUM
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:40032-024-60 1 TUBE in 1 CARTON contains a TUBE
1 60 g in 1 TUBE This package is contained within the CARTON (40032-024-60)
2 NDC:40032-024-61 1 TUBE in 1 CARTON contains a TUBE
2 15 g in 1 TUBE This package is contained within the CARTON (40032-024-61)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA206792 05/10/2016
Labeler — Novel Laboratories, Inc. (793518643)
Registrant — Novel Laboratories, Inc. (793518643)
Establishment
Name Address ID/FEI Operations
Novel Laboratories, Inc. 793518643 analysis (40032-024), manufacture (40032-024)

Revised: 06/2016 Novel Laboratories, Inc.

Page 2 of 2 1 2

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2023. All Rights Reserved.